Zepp Health Reports Q2 Non-GAAP EPADS Loss of $0.79 and Revenue Growth to $63.5M
In its second-quarter financial report, Zepp Health (ZEPP) reported a non-GAAP earnings per diluted share (EPADS) loss of -$0.79 with revenue reaching $63.5 million, representing a 6.9% year-over-year increase. As of June 30, the company held cash and restricted cash totaling $106.3 million, up from both the previous quarter ($103.2M) and last year's figure ($95.3M). The results reflect continued growth in revenue despite ongoing losses. Zepp Health also provided a Q3 outlook as part of its earnings release, though specific guidance figures were not detailed in this summary. Investors are likely to focus on the company’s cash reserves and how it plans to sustain operations while managing expenses amid rising revenues.
Tickers: $ZEPP
Topics: cash_balance non-gaap_eps revenue